Carnitine-acylcarnitine translocase deficiency: case report and review of the literature

M.E. Rubio-Gozalbo; P. Vos; Ph. Forget; S.B. van der Meer; R.J. Wanders; H.R. Waterham; J.A. Bakker

doi:10.1111/j.1651-2227.2003.tb00586.x

Carnitine-acylcarnitine translocase deficiency: case report and review of the literature

M.E. Rubio-Gozalbo^*, P. Vos, Ph. Forget, S.B. van der Meer, R.J. Wanders, H.R. Waterham, J.A. Bakker

^*Corresponding author for this work

NUTRIM School of Nutrition and Translational Research in Metabolism

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Carnitine-acylcarnitine translocase deficiency: case report and review of the literature.

Rubio-Gozalbo ME, Vos P, Forget PP, Van Der Meer SB, Wanders RJ, Waterham HR, Bakker JA.

Departments of Pediatrics, University Hospital Maastricht, The Netherlands. mrub@groupwise.azm.nl

AIM: Carnitine-acylcarnitine translocase (CACT) deficiency is an inborn error of metabolism involving the mitochondrial beta-oxidation of long-chain fatty acids. The aim of this study was to report on a new case (neonatal phenotype) and review the literature data on 24 previously reported cases. METHODS: Clinical data of the new case are described and compared with the previous reports. RESULTS: The patient with a novel mutation had clinical features and biochemical findings similar to those of the other reported patients. CONCLUSION: CACT is an entity in which clinical encephalopathy, hepatomegaly and arrythmias are common. Hyperammonaemia and elevation of creatine kinase seem to be constant findings as in other disorders of mitochondrial beta-oxidation of long-chain fatty acids. The mortality rate is very high.

Original language	English
Pages (from-to)	501-504
Number of pages	4
Journal	Acta Paediatrica
Volume	92
Issue number	4
DOIs	https://doi.org/10.1111/j.1651-2227.2003.tb00586.x
Publication status	Published - 1 Jan 2003

Access to Document

10.1111/j.1651-2227.2003.tb00586.x

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12801121&dopt=Abstract

Cite this

@article{b0a316519e1c4629abc46a79f34f76f8,

title = "Carnitine-acylcarnitine translocase deficiency: case report and review of the literature",

abstract = "Carnitine-acylcarnitine translocase deficiency: case report and review of the literature.Rubio-Gozalbo ME, Vos P, Forget PP, Van Der Meer SB, Wanders RJ, Waterham HR, Bakker JA.Departments of Pediatrics, University Hospital Maastricht, The Netherlands. mrub@groupwise.azm.nlAIM: Carnitine-acylcarnitine translocase (CACT) deficiency is an inborn error of metabolism involving the mitochondrial beta-oxidation of long-chain fatty acids. The aim of this study was to report on a new case (neonatal phenotype) and review the literature data on 24 previously reported cases. METHODS: Clinical data of the new case are described and compared with the previous reports. RESULTS: The patient with a novel mutation had clinical features and biochemical findings similar to those of the other reported patients. CONCLUSION: CACT is an entity in which clinical encephalopathy, hepatomegaly and arrythmias are common. Hyperammonaemia and elevation of creatine kinase seem to be constant findings as in other disorders of mitochondrial beta-oxidation of long-chain fatty acids. The mortality rate is very high.",

author = "M.E. Rubio-Gozalbo and P. Vos and Ph. Forget and {van der Meer}, S.B. and R.J. Wanders and H.R. Waterham and J.A. Bakker",

year = "2003",

month = jan,

day = "1",

doi = "10.1111/j.1651-2227.2003.tb00586.x",

language = "English",

volume = "92",

pages = "501--504",

journal = "Acta Paediatrica",

issn = "0803-5253",

publisher = "Wiley",

number = "4",

}

TY - JOUR

T1 - Carnitine-acylcarnitine translocase deficiency: case report and review of the literature

AU - Rubio-Gozalbo, M.E.

AU - Vos, P.

AU - Forget, Ph.

AU - van der Meer, S.B.

AU - Wanders, R.J.

AU - Waterham, H.R.

AU - Bakker, J.A.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Carnitine-acylcarnitine translocase deficiency: case report and review of the literature.Rubio-Gozalbo ME, Vos P, Forget PP, Van Der Meer SB, Wanders RJ, Waterham HR, Bakker JA.Departments of Pediatrics, University Hospital Maastricht, The Netherlands. mrub@groupwise.azm.nlAIM: Carnitine-acylcarnitine translocase (CACT) deficiency is an inborn error of metabolism involving the mitochondrial beta-oxidation of long-chain fatty acids. The aim of this study was to report on a new case (neonatal phenotype) and review the literature data on 24 previously reported cases. METHODS: Clinical data of the new case are described and compared with the previous reports. RESULTS: The patient with a novel mutation had clinical features and biochemical findings similar to those of the other reported patients. CONCLUSION: CACT is an entity in which clinical encephalopathy, hepatomegaly and arrythmias are common. Hyperammonaemia and elevation of creatine kinase seem to be constant findings as in other disorders of mitochondrial beta-oxidation of long-chain fatty acids. The mortality rate is very high.

AB - Carnitine-acylcarnitine translocase deficiency: case report and review of the literature.Rubio-Gozalbo ME, Vos P, Forget PP, Van Der Meer SB, Wanders RJ, Waterham HR, Bakker JA.Departments of Pediatrics, University Hospital Maastricht, The Netherlands. mrub@groupwise.azm.nlAIM: Carnitine-acylcarnitine translocase (CACT) deficiency is an inborn error of metabolism involving the mitochondrial beta-oxidation of long-chain fatty acids. The aim of this study was to report on a new case (neonatal phenotype) and review the literature data on 24 previously reported cases. METHODS: Clinical data of the new case are described and compared with the previous reports. RESULTS: The patient with a novel mutation had clinical features and biochemical findings similar to those of the other reported patients. CONCLUSION: CACT is an entity in which clinical encephalopathy, hepatomegaly and arrythmias are common. Hyperammonaemia and elevation of creatine kinase seem to be constant findings as in other disorders of mitochondrial beta-oxidation of long-chain fatty acids. The mortality rate is very high.

U2 - 10.1111/j.1651-2227.2003.tb00586.x

DO - 10.1111/j.1651-2227.2003.tb00586.x

M3 - Article

C2 - 12801121

SN - 0803-5253

VL - 92

SP - 501

EP - 504

JO - Acta Paediatrica

JF - Acta Paediatrica

IS - 4

ER -